 Home > Medical News > Latest Medical News > Luye Pharma and ESTEVE reach an agreement to commercialize a new Alzheimer's disease drug in Spain

Luye Pharma and ESTEVE reach an agreement to commercialize a new Alzheimer's disease drug in Spain

 Last Update: 2021-10-01
 Source: Internet
 Author: User

Tags

acyclovir used treat

alzheimer's disease test

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 16, Luye Pharmaceutical Group announced that its subsidiary, Luye Pharmaceuticals (Switzerland), has reached an agreement with Esteve Pharmaceuticals, SA to grant the latter the exclusive right to commercialize the Mindo Day transdermal patch of Liss in Spain

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.